1<!DOCTYPE html>
2
3Anonymous
4/bestp
5/bestp/domrep.nsf
68B344A7597F17DF9652580290045C861
8
9
10
11
12
13
140
15
16
17/bestp/domrep.nsf/products/8B344A7597F17DF9652580290045C861!OpenDocument
18
19OpenDocument
2044.200.168.16
21
22
23www.best-in-class.com
24/bestp/domrep.nsf
25DB




Products & Services Patient Focused Services Patient Advocacy Groups

Document Excerpt: Patient Advocacy Excellence: Optimizing Functional Structure & Managing Advocacy Relationships

DB Image

ID: MD-528


Features:

24 Info Graphics

19 Data Graphics

180+ Metrics

18 Narratives

11 Best Practices


Pages/Slides: 4


Published: Pre-2018


Delivery Format: Online PDF Document


 

License Options:


Download FREE Excerpt

 

919-403-0251

  • STUDY OVERVIEW
  • BENCHMARK CLASS
  • SPECIAL OFFER
To download this excerpt, click "Download Free Excerpt".

To return to the study abstract to purchase the full study – click here

This excerpt includes research findings and metrics from document #5427 "Patient Advocacy Excellence: Optimizing Functional Structure & Managing Advocacy Relationships”


Industries Profiled:
Biopharmaceutical; Pharmaceutical; Medical; Manufacturing; Biotech; Consumer Products; Diagnostic; Medical Device; Research; Health Care


Companies Profiled:
Alnylam Pharmaceuticals; Astellas; Baldwin Area Medical Center; Bayer; Boehringer Ingelheim; Covance; Forum Pharmaceuticals; Genzyme; Horizon Pharma; Johnson & Johnson; Lundbeck; Mallinckrodt; Natera; Novartis; Parkway Pantai; Pfizer; Pharmacyclics; Spark Therapeutics; Teva Pharmaceutical Industries Ltd; UCB Pharma; Zogenix

If you purchase Best Practice Database document(s), you will have 30 days from the date of purchase to apply some or all of the cost of the document(s) toward the cost of a Full Access Individual, Pharma, Group or University Membership. Write us at DatabaseTeam@bestpracticesllc.com or call David Guinn at 919-767-9179 if you have any questions.